Xenia Venture Capital
VC Fund
Herzliya, Israel
Xenia Venture Capital is an investment company publicly traded in the Tel-Aviv Stock Exchange that operates a technological incubator, and is engaged in the initiation and build-up of high-technology start up companies in Israel, in the fields of Information Technology and Life Sciences Medical devices.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Xenia Venture Capital invests in
Stages Xenia Venture Capital invests in
Countries Xenia Venture Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anat Segal
|
|||
Investment Focus
Industry
- Health Care 2 (22%)
- Gaming 1 (11%)
- Mobile 1 (11%)
- Medical 1 (11%)
- Software 1 (11%)
Stage
- Series C 4 (44%)
- Series B 3 (33%)
- Series A 1 (11%)
- Funding Round 1 (11%)
Country
- Israel 2 (22%)
- United States 2 (22%)
- United Kingdom 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Anat Segal
CEO
|
CEO | Total investments: 0 | Find email | |
Daphne Haim
VP Business Development Healthcare
|
VP Business Development Healthcare | Total investments: 0 | Find email | |
Eli Sorzon
CFO
|
CFO | Total investments: 0 | Find email | |
Ori Chochen
VP Business Development Hi-Tech
|
VP Business Development Hi-Tech | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technologywill tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide. | $25M / Series C / Oct 15, 2025 | ||
| keepMED develops a device for treatment of Obstructive Sleep Apnea, a disorder characterized by repetitive episodes of upper airway obstruction that occur during sleep. | $15.3M / Series C / Sep 29, 2020 | ||
| keepMED develops a device for treatment of Obstructive Sleep Apnea, a disorder characterized by repetitive episodes of upper airway obstruction that occur during sleep. | $10M / Series B / Apr 29, 2015 | ||
| keepMED develops a device for treatment of Obstructive Sleep Apnea, a disorder characterized by repetitive episodes of upper airway obstruction that occur during sleep. | $5M / Series A / Mar 29, 2015 | ||
| Correlix is a provider of latency management solutions for buy-side, sell-side, and exchange/trading firms. | Feb 14, 2012 | ||
| Correlix is a provider of latency management solutions for buy-side, sell-side, and exchange/trading firms. | $9M / Series C / May 23, 2011 | ||
| Playcast Media Systems brings video games to the world's largest media distribution platform Pay TV networks. The company's solution includes a head-end based system, which streams a game's audiovisual content as a standard MPEG stream, as well as the provisioning of the content and programming itself. Playcast's mediastreaming systems, located in operators headends, host the games and stream them over the existing video network to an already distributed base of set-top boxes. Playcast is a privately owned, venture capital backed company, based in Israel and the UK. | $10M / Series B / Jan 25, 2011 | ||
Superfish
|
Superfish is a developer and provider of an innovative, next-generation visual discovery platform that’s out to transform the way images are searched, seen, utilized, and shared over the web. Through its cutting-edge, patented technology and pioneering vision, Superfish has developed a cunningly intuitive visual search engine that analyzes imagesalgorithmically, without the need for text tags or human intervention. The company is reinventing image search and focusing on empowering consumers and businesses to experience new ways to engage with and search visual content. Founded in 2006 by Adi Pinhas and Michael Chertok, Superfish is headquartered in Palo Alto, California, and is backed by Draper Fisher Jurvetson (DFJ). | $4M / Series C / Nov 11, 2010 | |
| Correlix is a provider of latency management solutions for buy-side, sell-side, and exchange/trading firms. | $8M / Series B / Sep 02, 2008 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Xenia Venture Capital invest in?
Xenia Venture Capital invests primarily in Health Care, Gaming and Mobile startups, most often at Series C and Series B stage. Most of the 9 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Xenia Venture Capital?
Public channels for Xenia Venture Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Xenia Venture Capital?
The team at Xenia Venture Capital includes Anat Segal (CEO), Daphne Haim (VP Business Development Healthcare) and Eli Sorzon (CFO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
